These 4 ASX shares have grown more than 100% this year

While everyone has been investing in BNPL shares, plenty of other ASX shares have seen their share prices rise by over 100%. We take a look.

| More on:
large blue block digits saying one hundred per cent representing asx shares that have grown

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While everyone has been busy looking at buy now, pay later (BNPL) shares, there are plenty of other ASX shares that have also grown considerably since the start of the year. Each of the following companies has developed a solid foundation based on innovative technology, patents, or medical research. As such, I think it's likely that these ASX shares will continue to grow. 

Whispir Ltd (ASX: WSP)

Whispir provides mass communication tools for organisations. Accordingly, it has won clients across a very diverse spectrum of Australian industries. To illustrate, some of these include Transport for NSW, RACQ, APA Group (ASX: APA), Roy Hill, and the country's number one health booking app, Health Engine. 

This ASX share rose by 9.65% on Friday alone, and has risen by 140.38% since the start of the year. The company has a high gross operating margin of 62%, and recurring revenues make up greater than 95% of its income. 

Zoono Group Ltd (ASX: ZNO)

Zoono is a very special ASX share. The company produces hand sanitiser which is certified against a range of bacteria and viruses. This includes the African Swine Flu, and on 28 February, it announced its product tested favourably in protecting against COVID-19. The company has rapidly scaled up production to keep up with escalating demand and has rapidly put together a range of distribution deals covering the globe. 

Over the past year, the Zoono share price has risen by 2,550%. Since 1 January it has risen by 207.25%.

Recce Pharmaceuticals Ltd (ASX: RCE)

Recce is a drug researcher working on synthetic antibiotics. In particular the company is working to develop treatments for antibiotic resistant super bugs. Moreover, the company is pioneering work on treatments for sepsis. According to the medical journal The Lancet, sepsis killed 11 million people in 195 countries in 2017. Right now, sepsis remains an unmet challenge.

The Recce share price has risen by 380.88% since 1 January. Interest piqued after the ASX share announced two of its products had been selected for a CSIRO trial into antiviral treatments for COVID-19.

Brainchip Holdings Ltd (ASX: BRN)

I think Brainchip is one of the year's great ASX shares. The company is the largest listed pure-play artificial intelligence company in the world. A range of security applications use its products for facial recognition and pattern recognition. This include casinos, subways and airports. 

The market has become more interested in Brainchip after the announcement that it had completed the wafer for its latest product. This is called a neuromorphic chip and is the first of its kind. In recent announcements, the company has entered into proof of concept partnerships across a range of sectors including gaming and autonomous cars. The Brainchip share price is up 760% in 2020.

Daryl Mather owns shares of Recce Pharmaceuticals Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Whispir Ltd. The Motley Fool Australia owns shares of APA Group. The Motley Fool Australia has recommended Whispir Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »